ArticleClinical rehabilitation2025
Validation of the Amputee Single Item Mobility Measure (AMPSIMM) and the abbreviated AMPSIMM-4 for amputee mobility.
Article in Clinical rehabilitation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- PROPREDICT Decision Support Tool: Using Evidence to Guide Precision Prosthesis Prescription and Rehabilitation Planning.Archives of physical medicine and rehabilitation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
ObjectiveTo evaluate the criterion and construct validity of the 7-category Amputee Single Item Mobility Measure (AMPSIMM) in a large contemporary dysvascular lower limb amputation population and propose an abbreviated 4-category version (AMPSIMM-4) whose mobility categories parallel the Medicare Functional Classification Levels (K-levels).DesignCohort study retrospectively identifying persons with their first lower limb amputation then prospectively collecting their self-reported mobility.SettingNational cohort identified through a large Veterans' Administration dataset.ParticipantsSix hundred and ninety-two participants aged 30 years and older, undergoing their first diabetes and/or peripheral artery disease-related amputation at the transmetatarsal, transtibial, or transfemoral level, with a subset of 60 consecutive participants with a self-reported K-level.Main measuresAMPSIMM, Locomotor Capability Index-5 (LCI-5), K-levels, and PROMIS Global-10 Physical (PROMIS-P), at one year post amputation.ResultsThe strength of the correlation between AMPSIMM and LCI-5 scores was large (Spearman's rho = .88;
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.